Nanomerics' Ophthalmology SAB Strengthened
Dr Sajjad Ahmad is a consultant ophthalmologist/corneal surgeon at Moorfields Eye Hospital and honorary senior clinical lecturer at the UCL Institute of Ophthalmology. His clinical expertise is in ocular surface and corneal inflammatory disease and ocular surface/corneal/anterior segment reconstruction of the eye. He has also developed a culture system for human corneal epithelial stem cells that has been successfully used in clinical trials nationally.
Prof Schatzlein, CEO of Nanomerics commented:" We are delighted to be able to work with Sajj and his clinical colleagues to help to shape our ocular pipeline in response to patient needs. The MET platform offers a safe and efficacious way to optimise drug exposure of various ocular tissues. Tailoring these will bring medicines that will be more efficacious, will require less frequent dosing and avoid vehicle related side effects and irritation."
Dr Ahad confirmed:"Nanomerics' MET platform offers a novel way of delivering therapeutics to the eye which has the potential to bring about a step change in terms of treatment options for a range of ocular diseases. I am looking forward to working with Nanomerics to develop the MET platform to bring genuine benefits to our patients."